AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11562580 — intervention group
Group type: COMPARATOR
Intervention: Uncoated extracorporeal circulation with full dose systemic heparinization (Group A)
Number of subjects: 119
Study 9690594 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine (IVRA)
Number of subjects: 16
Study 9690594 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 16
Study 7907732 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide spraying of the child's dwelling
Number of subjects: 0
Study 7907732 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 2683545 — intervention group
Group type: EXPERIMENTAL
Intervention: CHFV (combination of continuous positive pressure ventilation and high frequency ventilation)
Number of subjects: 47
Study 2683545 — intervention group
Group type: EXPERIMENTAL
Intervention: CHFV
Number of subjects: 47
Study 2683545 — intervention group
Group type: COMPARATOR
Intervention: CPPV (control group)
Number of subjects: 47
Study 31509018 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable trait of sensation seeking
Number of subjects: 552
Study 30103216 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin (single dose and multiple doses for 24 weeks)
Number of subjects: 0
Study 30103216 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofogliflozin (multiple doses for 24 weeks)
Number of subjects: 0
Study 29227124 — intervention group
Group type: EXPERIMENTAL
Intervention: Coached group (given information about ADHD symptoms)
Number of subjects: 2
Study 29227124 — intervention group
Group type: COMPARATOR
Intervention: Noncoached group (given no additional information)
Number of subjects: 2
Study 29227124 — intervention group
Group type: COMPARATOR
Intervention: Genuine ADHD group
Number of subjects: 2
Study 29227124 — intervention group
Group type: COMPARATOR
Intervention: Nonclinical group (asked to respond honestly)
Number of subjects: 2
Study 26283139 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous alteplase (0.6 mg/kg body weight)
Number of subjects: 0
Study 26283139 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose intravenous alteplase (0.9 mg/kg body weight)
Number of subjects: 0
Study 26283139 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive blood pressure lowering (systolic target 130-140 mmHg)
Number of subjects: 0
Study 26283139 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure control (systolic target <180 mmHg)
Number of subjects: 0
Study 23818039 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride (LM group)
Number of subjects: 165
Study 23818039 — intervention group
Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride (MH group)
Number of subjects: 165
Study 23818039 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PP group)
Number of subjects: 165
Study 21600676 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention programme centered on the regulation of emotions
Number of subjects: 52
Study 21600676 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 19627532 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided ilioinguinal nerve block with 0.1 ml x kg(‐1) of 0.25% bupivacaine with 1 : 200,000 epinephrine
Number of subjects: 50
Study 19627532 — intervention group
Group type: COMPARATOR
Intervention: Single-shot caudal block with 0.7 ml x kg(‐1) of 0.125% bupivacaine with 1 : 200,000 epinephrine
Number of subjects: 50
Study 19627532 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided ilioinguinal nerve block
Number of subjects: 50
Study 19627532 — intervention group
Group type: COMPARATOR
Intervention: Single-shot caudal block
Number of subjects: 50
Study 17101847 — intervention group
Group type: EXPERIMENTAL
Intervention: RB006 (anticoagulant)
Number of subjects: 85
Study 17101847 — intervention group
Group type: EXPERIMENTAL
Intervention: RB007 (antidote)
Number of subjects: 85
Study 17101847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 15561322 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40-80 mg once daily for 1 year
Number of subjects: 85
Study 11731185 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate (2 mg) for 21 days
Number of subjects: 20
Study 11731185 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate (2 mg) for 11 days and cyproterone acetate (1 mg) for 10 days
Number of subjects: 20
Study 11731185 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate alone
Number of subjects: 20
Study 11731185 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate in association with cyproterone acetate
Number of subjects: 20
Study 11731185 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate alone or in association with cyproterone acetate
Number of subjects: 20
Study 9530055 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous needle aspiration
Number of subjects: 50
Study 9530055 — intervention group
Group type: COMPARATOR
Intervention: Catheter drainage
Number of subjects: 50
Study 9530055 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study 1882895 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate tablets, 4 g/day for 8 weeks
Number of subjects: 48
Study 1882895 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine, 1.6 g/day for 8 weeks
Number of subjects: 48
Study 6346962 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide aerosol
Number of subjects: 34
Study 6346962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30902422 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular strength (measured by handgrip strength)
Number of subjects: 100
Study 30902422 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-agility
Number of subjects: 100
Study 30902422 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness and overall fitness Z-score
Number of subjects: 100
Study 30902422 — intervention group
Group type: COMPARATOR
Intervention: Physical activity and sedentary time
Number of subjects: 100
Study 29110518 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-appropriate preparation for children undergoing RT
Number of subjects: 33
Study 29110518 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard preparation)
Number of subjects: 33
Study 27028832 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine administered via intravenous (IV) route
Number of subjects: 15
Study 27028832 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine administered via intramuscular (IM) route
Number of subjects: 15
Study 27028832 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine administered via subcutaneous (SC) route
Number of subjects: 15
Study 27028832 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (control treatment)
Number of subjects: 15
Study 23576020 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CRT) with cisplatin (40 mg/m2 weekly during RT, followed by cisplatin (80 mg/m2) and fluorouracil (800 mg/m2) daily for 5 days every 4 weeks for 3 cycles)
Number of subjects: 316
Study 23576020 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 316
Study 21851917 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement intervention (opportunities to win $1 to $100 prizes for losing weight and completing weight-loss activities)
Number of subjects: 56
Study 21851917 — intervention group
Group type: COMPARATOR
Intervention: Non-reinforcement condition (Lifestyle, Exercise, Attitudes, Relationships, Nutrition manual with supportive counseling)
Number of subjects: 56
Study 21851917 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforcement intervention
Number of subjects: 56
Study 21851917 — intervention group
Group type: COMPARATOR
Intervention: Non-reinforcement condition
Number of subjects: 56
Study 20533221 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient‐fortified salt
Number of subjects: 402
Study 20533221 — intervention group
Group type: COMPARATOR
Intervention: Iodized salt
Number of subjects: 402
Study 17245777 — intervention group
Group type: EXPERIMENTAL
Intervention: Group pelvic floor muscle training (PFMT) under intensive supervision (Group B)
Number of subjects: 30
Study 17245777 — intervention group
Group type: COMPARATOR
Intervention: Individual home therapy (Group A)
Number of subjects: 30
Study 15090951 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic povidone-iodine solution protocol
Number of subjects: 223
Study 15090951 — intervention group
Group type: COMPARATOR
Intervention: Aqueous 10% povidone-iodine solution protocol
Number of subjects: 223
Study 11213982 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 150 mg orally (50 mg rapid-release and 100 mg prolonged-release)
Number of subjects: 30
Study 11213982 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg orally (prolonged-release) and 50 mg intramuscularly
Number of subjects: 30
Study 11213982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11213982 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (equal doses)
Number of subjects: 30
Study 11783221 — intervention group
Group type: EXPERIMENTAL
Intervention: Huodan Tablet
Number of subjects: 0
Study 11783221 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 0
Study 7991079 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect memory performance for abstract shapes (copying speed)
Number of subjects: 12
Study 7991079 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-choice recognition of shapes
Number of subjects: 12
Study 2663152 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 42
Study 2663152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 2663152 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone or another antidepressant
Number of subjects: 42
Study 4818344 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin treatment
Number of subjects: 0
Study 4818344 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 0
Study 4818344 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 0
Study 31771410 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation
Number of subjects: 71
Study 31771410 — intervention group
Group type: COMPARATOR
Intervention: Control group (in-person care)
Number of subjects: 71
Study 31517677 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Pleth Index (SPI)
Number of subjects: 48
Study 31517677 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupillary Pain Index (PPI)
Number of subjects: 48
Study 31517677 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociception Level (NoL)
Number of subjects: 48
Study 31517677 — intervention group
Group type: COMPARATOR
Intervention: Clinical judgment (control)
Number of subjects: 48
Study 31517677 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI
Number of subjects: 48
Study 31517677 — intervention group
Group type: EXPERIMENTAL
Intervention: NoL
Number of subjects: 48
Study 31517677 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 31517677 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI
Number of subjects: 48
Study 29187423 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) follow-up care
Number of subjects: 182
Study 29187423 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient care (SOC)
Number of subjects: 182
Study 28333187 — intervention group
Group type: EXPERIMENTAL
Intervention: Eldelumab 20 mg/kg
Number of subjects: 121
Study 28333187 — intervention group
Group type: EXPERIMENTAL
Intervention: Eldelumab 10 mg/kg
Number of subjects: 121
Study 28333187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 28333187 — intervention group
Group type: EXPERIMENTAL
Intervention: Eldelumab (both doses)
Number of subjects: 121
Study 26465664 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal warm-up
Number of subjects: 31
Study 26465664 — intervention group
Group type: COMPARATOR
Intervention: Breathing training
Number of subjects: 31
Study 23621698 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapy with infliximab 5 mg kg(‐1) every 8 weeks
Number of subjects: 441
Study 23621698 — intervention group
Group type: COMPARATOR
Intervention: Intermittent therapy (no infliximab until > 50% loss of PASI improvement)
Number of subjects: 441
Study 21252632 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly SMS reminders
Number of subjects: 431
Study 21252632 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 431
Study 18450869 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborn Individualized Developmental Care and Assessment Program care
Number of subjects: 36
Study 18450869 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 36
Study 16531506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower birth weight (LBW) group
Number of subjects: 29
Study 16531506 — intervention group
Group type: COMPARATOR
Intervention: Higher birth weight (HBW) group
Number of subjects: 29
Study 15055982 — intervention group
Group type: EXPERIMENTAL
Intervention: 19% sodium percarbonate gel
Number of subjects: 50
Study 15055982 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 50
Study 11899648 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 114
Study 11899648 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 114
Study 9197167 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 800 mg tid for 10 days combined with needle aspiration (group A)
Number of subjects: 29
Study 9197167 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole therapy alone (group B)
Number of subjects: 29
Study 8298940 — intervention group
Group type: COMPARATOR
Intervention: Control group (Haemoccult screening)
Number of subjects: 405
Study 3812347 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified milk
Number of subjects: 0
Study 3812347 — intervention group
Group type: COMPARATOR
Intervention: Nonfortified milk
Number of subjects: 0
Study 3812347 — intervention group
Group type: COMPARATOR
Intervention: Noncompliant fortified group
Number of subjects: 0
Study 31912170 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery (RS)
Number of subjects: 0
Study 31912170 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery (LS)
Number of subjects: 0
Study 28506442 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical primes during morphosyntactic training exercises (8 sessions)
Number of subjects: 10
Study 28506442 — intervention group
Group type: COMPARATOR
Intervention: Neutral baseline primes (environmental sounds) during morphosyntactic training exercises (8 sessions)
Number of subjects: 10
Study 28506442 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical primes
Number of subjects: 10
Study 28506442 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention tasks
Number of subjects: 10
Study 28506442 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory tasks
Number of subjects: 10
Study 27043120 — intervention group
Group type: EXPERIMENTAL
Intervention: CurQfen (curcumagalactomannoside [CGM]) 500 mg twice daily for 30 days
Number of subjects: 60
Study 27043120 — intervention group
Group type: COMPARATOR
Intervention: Standard curcumin
Number of subjects: 60
Study 27043120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24184388 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (30 mg)
Number of subjects: 20
Study 24184388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21819446 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) - 5 × 1 min of unilateral isometric squat exercise on a synchronous vibrating platform [30 Hz, 4 mm peak‐to‐peak amplitude]
Number of subjects: 14
Study 21819446 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CON) - same exercise without WBV
Number of subjects: 14
Study 21946190 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap vaccine (5-pertussis-component)
Number of subjects: 0
Study 21946190 — intervention group
Group type: COMPARATOR
Intervention: No vaccine (control group)
Number of subjects: 0
Study 18289869 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIg)
Number of subjects: 22
Study 18289869 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunosuppressive therapy (CIST)
Number of subjects: 22
Study 16537263 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐Assisted Memory Training Group (CAMG)
Number of subjects: 37
Study 16537263 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist‐administered Memory Training Group (TAMG)
Number of subjects: 37
Study 16537263 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 37
Study 12783233 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine (ACh)
Number of subjects: 0
Study 12783233 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal unstimulated perfusion
Number of subjects: 0
Study 12783233 — intervention group
Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 0
Study 10735888 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus CMF (cyclophosphamide, methotrexate, fluorouracil)
Number of subjects: 608
Study 10735888 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen alone
Number of subjects: 608
Study 10735888 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF plus tamoxifen
Number of subjects: 608
Study 8958002 — intervention group
Group type: EXPERIMENTAL
Intervention: Malted-oat porridge with 107 mumol phytate
Number of subjects: 10
Study 8958002 — intervention group
Group type: COMPARATOR
Intervention: Control porridge with 432 mumol phytate
Number of subjects: 10
Study 8958002 — intervention group
Group type: EXPERIMENTAL
Intervention: Malted-oat porridge with 107 mumol phytate (Expt 2)
Number of subjects: 10
Study 8958002 — intervention group
Group type: COMPARATOR
Intervention: Control porridge with 437 mumol phytate
Number of subjects: 10
Study 8958002 — intervention group
Group type: EXPERIMENTAL
Intervention: Malted porridge with 198 mumol phytate (Expt 3)
Number of subjects: 10
Study 8958002 — intervention group
Group type: COMPARATOR
Intervention: Control porridge with 599 mumol phytate
Number of subjects: 10
Study 1488468 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (7 mg/kg)
Number of subjects: 14
Study 2857265 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental diet high in polyunsaturated fat and low in saturated fat with daily supplement of 1.8 g eicosapentaenoic acid
Number of subjects: 37
Study 2857265 — intervention group
Group type: COMPARATOR
Intervention: Control diet with lower polyunsaturated to saturated fat ratio and placebo supplement
Number of subjects: 37
Study 30854818 — intervention group
Group type: EXPERIMENTAL
Intervention: XPF 3 mL of 3% NaOCl for 1 min (group A)
Number of subjects: 60
Study 30854818 — intervention group
Group type: EXPERIMENTAL
Intervention: PUI of 3 mL of 3% NaOCl for 1 min (group C)
Number of subjects: 60
Study 30854818 — intervention group
Group type: COMPARATOR
Intervention: 3 mL of 3% NaOCl for 1 min by using a syringe and a 30 G side‐vented needle (group E)
Number of subjects: 60
Study 30854818 — intervention group
Group type: EXPERIMENTAL
Intervention: XPF 3 mL of 3% NaOCl for 1 min, followed by 4 mL of 17% EDTA for 1 min (group B)
Number of subjects: 60
Study 30854818 — intervention group
Group type: EXPERIMENTAL
Intervention: PUI of 3 mL of 3% NaOCl for 1 min, followed by 4 mL of 17% EDTA for 1 min (group D)
Number of subjects: 60
Study 30854818 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL of 3% NaOCl for 1 min by using a syringe and a 30 G side‐vented needle, followed by 4 mL of 17% EDTA for 1 min (group F)
Number of subjects: 60
Study 29436706 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS)
Number of subjects: 13
Study 29436706 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (control)
Number of subjects: 13
Study 26785826 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone (dosage not specified)
Number of subjects: 0
Study 25414061 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal hybrid NOTES
Number of subjects: 58
Study 25414061 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic‐assisted sigmoid resection
Number of subjects: 58
Study 23017985 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic exercise program (3 times per week for 8 weeks, 60 minutes per session)
Number of subjects: 68
Study 23017985 — intervention group
Group type: COMPARATOR
Intervention: Usual care (following oncologist's recommendations)
Number of subjects: 68
Study 20447123 — intervention group
Group type: EXPERIMENTAL
Intervention: Medmont automated perimeter (MAP)
Number of subjects: 63
Study 20447123 — intervention group
Group type: COMPARATOR
Intervention: Humphrey field analyser (HFA)
Number of subjects: 63
Study 18725429 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger expression condition (telling stories about people depicted in pictures)
Number of subjects: 84
Study 18725429 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger inhibition condition (describing objects appearing in pictures)
Number of subjects: 84
Study 16173015 — intervention group
Group type: EXPERIMENTAL
Intervention: GigHAART therapy after an 8-week treatment interruption (TI)
Number of subjects: 0
Study 16173015 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple drug salvage regimen
Number of subjects: 0
Study 16173015 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined factor of PI concentration and genotypic score (GIQ)
Number of subjects: 0
Study 12887479 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once-daily
Number of subjects: 955
Study 12887479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955
Study 10482340 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenergic antidepressant desipramine (n = 38)
Number of subjects: 76
Study 10482340 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin re‐uptake inhibitor (paroxetine or sertraline) (n = 38)
Number of subjects: 76